KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Return on Equity (2016 - 2026)

Abbott Laboratories' Return on Equity history spans 18 years, with the latest figure at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, down 107.0% from a year prior.
  • Return on Equity hit 0.0% in Q1 2026 for Abbott Laboratories, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for ABT hit a ceiling of 1.44% in Q4 2024 and a floor of 0.02% in Q2 2022.
  • Historically, Return on Equity has averaged 0.17% across 5 years, with a median of 0.0% in 2025.
  • Biggest five-year swings in Return on Equity: surged 145bps in 2024 and later tumbled -144bps in 2025.
  • Tracing ABT's Return on Equity over 5 years: stood at 0.01% in 2022, then tumbled by -199bps to 0.01% in 2023, then surged by 10725bps to 1.44% in 2024, then crashed by -100bps to 0.0% in 2025, then fell by -5bps to 0.0% in 2026.
  • Business Quant data shows Return on Equity for ABT at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.